相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Risk prediction of atrial fibrillation in the community combining biomarkers and genetics
Christin S. Boerschel et al.
EUROPACE (2021)
Identification of key immune-related genes and immune infiltration in atrial fibrillation with valvular heart disease based on bioinformatics analysis
Shuo Li et al.
JOURNAL OF THORACIC DISEASE (2021)
Cohort Profile: The National FINRISK Study
Katja Borodulin et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2018)
Association of fibrotic remodeling and cytokines/chemokines content in epicardial adipose tissue with atrial myocardial fibrosis in patients with atrial fibrillation
Ichitaro Abe et al.
HEART RHYTHM (2018)
Discovery of new biomarkers for atrial fibrillation using a custom-made proteomics chip
Lars Lind et al.
HEART (2017)
Plasma levels of hepatocyte growth factor and placental growth factor predict mortality in a general population: a prospective cohort study
K. Santalahti et al.
JOURNAL OF INTERNAL MEDICINE (2017)
Inflammatory Biomarkers Predict Heart Failure Severity and Prognosis in Patients With Heart Failure With Preserved Ejection Fraction A Holistic Proteomic Approach
Camilla Hage et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2017)
Genome-wide Association Study Identifies 27 Loci Influencing Concentrations of Circulating Cytokines and Growth Factors
Ari V. Ahola-Olli et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2017)
NT-proBNP is a powerful predictor for incident atrial fibrillation - Validation of a multimarker approach
Emma Svennberg et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Circulating Cytokines Predict the Development of Insulin Resistance in a Prospective Finnish Population Cohort
Kristiina Santalahti et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies
Moritz F. Sinner et al.
EUROPACE (2014)
Clinical Classifications of Atrial Fibrillation Poorly Reflect Its Temporal Persistence Insights From 1,195 Patients Continuously Monitored With Implantable Devices
Efstratios I. Charitos et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Circulating cytokines in predicting development of severe acute pancreatitis
Anne Nieminen et al.
CRITICAL CARE (2014)
Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference
Paulus Kirchhof et al.
EUROPACE (2013)
Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060
Bouwe P. Krijthe et al.
EUROPEAN HEART JOURNAL (2013)
Hepatocyte growth factor and basic fibroblast growth factor regulate atrial fibrosis in patients with atrial fibrillation and rheumatic heart disease via the mitogen-activated protein kinase signaling pathway
Mingjiang Li et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2013)
Simple Risk Model Predicts Incidence of Atrial Fibrillation in a Racially and Geographically Diverse Population: the CHARGE-AF Consortium
Alvaro Alonso et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)
Role of inflammation and oxidative stress in atrial fibrillation
Jie Li et al.
HEART RHYTHM (2010)
Intracardiac and extracardiac markers of inflammation during atrial fibrillation
Gregory M. Marcus et al.
HEART RHYTHM (2010)
Does Elevated C-Reactive Protein Increase Atrial Fibrillation Risk? A Mendelian Randomization of 47,000 Individuals From the General Population
Sarah C. W. Marott et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Source of inflammatory markers in patients with atrial fibrillation
Ioan Liuba et al.
EUROPACE (2008)
Reduced high serum hepatocyte growth factor levels after successful cardioversion in patients with atrial fibrillation
H Katoh et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2004)
分享论文
